Montana legislation · 2025 Regular Session
Montana SB211: Revise emergency use of epinephrine in school setting to include nasal spray
Status: Signed into law, April 17, 2025
What the bill says
An act revising the emergency use of epinephrine in a school setting to include nasal spray; amending sections 20-5-420 and 20-5-421, mca; and providing an immediate effective date.
From the engrossed text:
AN ACT REVISING THE EMERGENCY USE OF EPINEPHRINE IN A SCHOOL SETTING TO INCLUDE NASAL SPRAY; AMENDING SECTIONS 20-5-420 AND 20-5-421, MCA; AND PROVIDING AN IMMEDIATE EFFECTIVE DATE. Section 1. Section 20-5-420, MCA, is amended to read: "20-5-420. Self-administration or possession of asthma, severe allergy, or anaphylaxis medication. (1) As used in 20-5-421 and this section, the following definitions apply: (a) "Anaphylaxis" means a systemic allergic reaction that can be fatal in a short time period and is also known as anaphylactic shock. (b) "Asthma" means a chronic disorder or condition of the lungs that requires lifetime, ongoing medical intervention. (c) "Medication" means a medicine, including inhaled bronchodilators, inhaled corticosteroids, and autoinjectable epinephrine, and epinephrine nasal spray, prescribed by a licensed physician as defined in 37-3102, a physician assistant who has been authorized to prescribe medications as provided in 37-20-404, or an advanced practice registered nurse with prescriptive authority as provided in 37-8-202(1)(h). (d) "Self-administration" means a pupil's discretionary use of the medication prescribed for the pupil. (e) "Severe allergies" means a life-threatening hypersensitivity to a specific substance such as food, pollen, or dust. (2) A school, whether public or nonpublic, shall permit the possession or self-administration of medication, as prescribed, by a pupil with asthma, severe allergies, or anaphylaxis if the parents or guardians of the pupil provide to …
Sponsors
- Neumann, Cora (D, 30) · primary sponsor
- Weber, Jane (D, 19)
Latest actions
- : Chapter Number Assigned
- : (S) Signed by Governor
- : (S) Transmitted to Governor
- : (H) Signed by Speaker
- : (S) Signed by President
- : (S) Returned from Enrolling
- : (S) Sent to Enrolling
- : (H) 3rd Reading Concurred
- : (H) 3rd Reading
- : (H) 2nd Reading Concurred
Votes
- Do Concur (March 26, 2025): 85 yea, 14 nay, passed
- Do Concur (March 25, 2025): 81 yea, 18 nay, passed
- Do Pass (February 12, 2025): 50 yea, 0 nay, passed
- Do Pass (February 11, 2025): 48 yea, 1 nay, passed
Subjects: Health Care Services, Education - K-12
Common questions
- What is SB211?
- SB211 is a bill in the Montana Legislature (2025 Regular Session): Revise emergency use of epinephrine in school setting to include nasal spray.
- What does SB211 do?
- In its own words: An act revising the emergency use of epinephrine in a school setting to include nasal spray; amending sections 20-5-420 and 20-5-421, mca; and providing an immediate effective date.
- What is the status of SB211?
- Signed into law as of April 17, 2025. Latest action: Chapter Number Assigned (April 17, 2025).
- Who sponsored SB211?
- Neumann, Cora (D, 30), with 1 co-sponsor.
- Where is the official record for SB211?
- On the Montana Legislature website: https://bills.legmt.gov/#/laws/bill/2/LC1412
Source: official Montana record. Tracked by Delilah, AI for legislation across all 50 states and Congress.